Products

Mogamulizumab (Gly-007CL)

Mogamulizumab (USAN; trade name Poteligeo) is a humanized monoclonal antibody targeting CC chemokine receptor 4 (CCR4). It was approved in 2012 for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma.      

Specifications
Type
Humanized (from mouse) Whole antibody
Protein Chemical Formula
C6520H10072N1736O2020S42
Protein Average Weight
146.44 kg/mol
CAS NO.
1159266-37-1
Mechanism of Action
CCR4 receptor antagonists
References
Alternative Names
Poteligeo (mogamulizumab; AMG-761; KW-0761); AMG 761; KM8761

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-381-2994    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2018 Creative-Biolabs All Rights Reserved